Header Logo

Connection

Sara Vesely to Oklahoma

Back to Details
This is a "connection" page, showing publications Sara Vesely has written about Oklahoma.
Sara Vesely
Connection Strength
1.045
Oklahoma
  1. Life after acquired thrombotic thrombocytopenic purpura: morbidity, mortality, and risks during pregnancy. J Thromb Haemost. 2015 Jun; 13 Suppl 1:S216-22.
    View in: PubMed
    Score: 0.098
  2. The influence of assets and environmental factors on gender differences in adolescent drug use. J Adolesc. 2014 Aug; 37(6):827-37.
    View in: PubMed
    Score: 0.092
  3. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524.
    View in: PubMed
    Score: 0.079
  4. Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43.
    View in: PubMed
    Score: 0.073
  5. Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008; 23(4):129-37.
    View in: PubMed
    Score: 0.059
  6. Effect Modification of the Association Between Race and Stage at Colorectal Cancer Diagnosis by Socioeconomic Status. J Public Health Manag Pract. 2019 Sep/Oct; 25 Suppl 5, Tribal Epidemiology Centers: Advancing Public Health in Indian Country for Over 20 Years:S29-S35.
    View in: PubMed
    Score: 0.033
  7. Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists. J Thromb Thrombolysis. 2018 Jul; 46(1):24-30.
    View in: PubMed
    Score: 0.030
  8. Adolescent Pregnancy Prevention Among Youths Living in Group Care Homes: A Cluster Randomized Controlled Trial. Am J Public Health. 2018 02; 108(S1):S38-S44.
    View in: PubMed
    Score: 0.029
  9. Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol. 2017 Nov; 92(11):E644-E646.
    View in: PubMed
    Score: 0.029
  10. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695.
    View in: PubMed
    Score: 0.028
  11. Short-Term Impact of a Teen Pregnancy-Prevention Intervention Implemented in Group Homes. J Adolesc Health. 2016 11; 59(5):584-591.
    View in: PubMed
    Score: 0.027
  12. Pancreatic Cancer: A Survival Analysis Study in Oklahoma. J Okla State Med Assoc. 2016 Jul-Aug; 109(7-8):391-398.
    View in: PubMed
    Score: 0.026
  13. Patterns of Care for Localized Breast Cancer in Oklahoma, 2003-2006. Women Health. 2015; 55(8):975-95.
    View in: PubMed
    Score: 0.025
  14. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol. 2015 May; 90(5):406-10.
    View in: PubMed
    Score: 0.024
  15. Prospective association between negative life events and initiation of sexual intercourse: the influence of family structure and family income. Am J Public Health. 2015 Mar; 105(3):598-604.
    View in: PubMed
    Score: 0.024
  16. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4.
    View in: PubMed
    Score: 0.022
  17. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014 Mar 13; 123(11):1674-80.
    View in: PubMed
    Score: 0.022
  18. Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol. 2014 Feb; 92(2):156-63.
    View in: PubMed
    Score: 0.022
  19. The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care. Hamostaseologie. 2013 May 29; 33(2):105-12.
    View in: PubMed
    Score: 0.021
  20. Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7.
    View in: PubMed
    Score: 0.020
  21. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52.
    View in: PubMed
    Score: 0.020
  22. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51.
    View in: PubMed
    Score: 0.019
  23. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9.
    View in: PubMed
    Score: 0.018
  24. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol. 2010 Nov; 85(11):844-7.
    View in: PubMed
    Score: 0.018
  25. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010 Feb 25; 115(8):1500-11; quiz 1662.
    View in: PubMed
    Score: 0.017
  26. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
    View in: PubMed
    Score: 0.016
  27. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
    View in: PubMed
    Score: 0.016
  28. Methodological considerations in a community-based longitudinal study. Am J Health Behav. 2009 Jan-Feb; 33(1):58-68.
    View in: PubMed
    Score: 0.016
  29. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24.
    View in: PubMed
    Score: 0.015
  30. Protective assets for non-use of alcohol, tobacco and other drugs among urban American Indian youth in Oklahoma. Matern Child Health J. 2008 Jul; 12 Suppl 1:82-90.
    View in: PubMed
    Score: 0.015
  31. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol. 2008 Apr; 80(4):277-86.
    View in: PubMed
    Score: 0.015
  32. Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher. 2008; 23(5):168-9.
    View in: PubMed
    Score: 0.015
  33. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc. 2007 Nov; 100(11):429-33.
    View in: PubMed
    Score: 0.014
  34. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc. 2007 Jul; 100(7):273-8.
    View in: PubMed
    Score: 0.014
  35. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007 Jan; 12(1):11-9.
    View in: PubMed
    Score: 0.014
  36. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7.
    View in: PubMed
    Score: 0.011
  37. Tobacco cessation attitudes and behaviors among Oklahoma high school students. J Okla State Med Assoc. 2002 Mar; 95(3):176-9.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.